Table 2.
Distributions used as priors for model parameters. Test performance parameters are beta-distributed based on literature studies with with parameters (α, β) as given, equal to one plus the numbers of positive and negative results in the study, respectively. The rates of spontaneous recovery and treatment seeking were sampled using Markov Chain Monte Carlo methods (see main text). The proportion of the population who were sexually active is a beta distribution with parameters such that its central 95% credible interval matches the 95% confidence interval for the proportion estimated from Natsal-3. The proportion of incident infections which are asymptomatic was calibrated so that the sampled prevalence in 15-24-year-olds matched the Natsal estimates (see main text).
| Parameter Description | Population | α | β | Mean (95% range: (2.5th, 97.5th) centiles) | Reference | |
|---|---|---|---|---|---|---|
| Test performance: sensitivity; probability of a positive result, given infected | men | 33 | 1 | 0.971 (0.894, 0.999) | 6 | |
| women | 130 | 13 | 0.909 (0.857, 0.950) | 7 | ||
| Test performance: (1-specificity); probability of a positive result, given uninfected | men | 3 | 951 | 0.00314 (0.00065, 0.00756) | 6 | |
| women | 5 | 2324 | 0.00215 (0.00070, 0.00439) | 7 | ||
| Rate of spontaneous recovery (year-1) | men | Distribution sampled using Markov Chain Monte Carlo methods. | 0.470 (0.059, 1.274) | 8,10–17 | ||
| women | 0.728 (0.591, 0.874) | 8,12–15,18–22 | ||||
| Rate of treatment seeking (year-1) | men | Distribution sampled using Markov Chain Monte Carlo methods. | 14.4 (8.5, 22.9) | 23 | ||
| women | 14.4 (8.5, 22.9) | 23 | ||||
| Proportion of population sexually active | men | 16-19 years | 506 | 208 | 0.709 (0.675, 0.741) | 25 |
| 20-24 years | 467 | 45.8 | 0.911 (0.885, 0.934) | |||
| 16-24 years | 1090 | 234 | 0.823 (0.802, 0.843) | |||
| women | 16-19 years | 532 | 238 | 0.691 (0.658, 0.723) | 25 | |
| 20-24 years | 569 | 53.8 | 0.914 (0.890, 0.934) | |||
| 16-24 years | 1280 | 283 | 0.819 (0.799, 0.838) | |||
| Proportion of incident infections that are asymptomatic | men | Calibrated to reproduce Natsal-3 prevalence | 0.511 (0.264, 0.759) | 2 | ||
| women | 0.615 (0.468, 0.752) | |||||